Tlry stock price stayed range-bound between $1

TLRY stock price stayed range-bound between $1.77 and $1.82, reflecting cautious positioning ahead of quarterly results. Options activity in the $2 calls has increased, possibly hinting at bullish bets for Q1. Tilray (TLRY) shares closed nearly 60% higher on Sept. 29 after President Donald Trump promoted cannabidiol’s (CBD) potential to “revolutionize senior healthcare” in a video posted on Truth Social. The newfound bullish momentum will soon face its first major test. Tilray is scheduled to report its first-quarter fiscal year 2026 financial results before the market opens on Oct. 9, 2025. This report will provide the first set of hard data since the fiscal year-end and will be crucial in determining if the recent rally can be sustained. Volume spikes indicate active day-trader participation, but macro headwinds from rising interest rates remain a dampener for risk assets.